Net profit of Divi`s Laboratories rose 46.55% to Rs 510.00 crore in the quarter ended September 2024 as against Rs 348.00 crore during the previous quarter ended September 2023. Sales rose 22.47% to Rs 2338.00 crore in the quarter ended September 2024 as against Rs 1909.00 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales2338.001909.00 22 OPM %30.6225.09 - PBDT821.00564.00 46 PBT722.00469.00 54 NP510.00348.00 47 Powered by Capital Market - Live News

Divis Laboratories will hold a meeting of the Board of Directors of the Company on 9 November 2024Powered by Capital Market - Live News

Divis Laboratories has received reaffirmation in credit ratings for bank facilities aggregating Rs 515 crore at CARE AA+; Stable/ CARE A1+ from CARE Ratings. Powered by Capital Market - Live News

Net profit of Divi`s Laboratories rose 20.79% to Rs 430.00 crore in the quarter ended June 2024 as against Rs 356.00 crore during the previous quarter ended June 2023. Sales rose 19.12% to Rs 2118.00 crore in the quarter ended June 2024 as against Rs 1778.00 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales2118.001778.00 19 OPM %29.3728.35 - PBDT701.00585.00 20 PBT604.00492.00 23 NP430.00356.00 21 Powered by Capital Market - Live News

Divis Laboratories will hold a meeting of the Board of Directors of the Company on 3 August 2024.Powered by Capital Market - Live News